Professor of Medicine, Wake Forest University
Nephrology
John D. Burkart, AUD
|
|
Give Review
John Burkart works in the field of Nephrology. He attended Rush Medical College. He has 2 awards "Regional Top Doctor" and "Top MD". John Burkart is a published doctor and has 96 publications published. The lastest was: 'Dialysis modality and delayed graft function after cadaveric renal transplantation.'
Publications
- Hemoglobin Stability and Patient Compliance With Darbepoetin Alfa in Peritoneal Dialysis Patients After the Implementation of the Prospective Payment System.
- Risk of Catheter-Related Bloodstream Infection in Elderly Patients on Hemodialysis.
- Comparative Outcomes Between Continuous Ambulatory and Automated Peritoneal Dialysis: A Narrative Review.
- Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).
- Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution.
- Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis.
- The ADEMEX study and its implications for peritoneal dialysis adequacy.
- What is the evidence that peritoneal dialysis is underutilized as an ESRD therapy?
- Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
- Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.
- Comparison of a 2.5% and a 4.25% dextrose peritoneal equilibration test.
- Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
- The ADEMEX study and PD adequacy.
- Combined peritoneal dialysis and hemodialysis: our experience compared to others.
- Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
- Peritoneal dialysate fill-volumes and hernia development in a cohort of peritoneal dialysis patients.
- Changes in peritoneal transport during the first month of peritoneal dialysis.
- 24-hour dialysate collection for determination of peritoneal membrane transport characteristics: longitudinal follow-up data for the dialysis adequacy and transport te...
- An elevated ratio of measured to predicted creatinine production in CAPD patients is not a sensitive predictor of noncompliance with the dialysis prescription.
- Comparison of exit-site infections in disconnect versus nondisconnect systems for peritoneal dialysis.
- The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients.
- Assessment of dialysis dose by measured clearance versus extrapolated data.
- Determination of peritoneal transport characteristics with 24-hour dialysate collections: dialysis adequacy and transport test.
- Frequency and causes of discrepancy between Kt/V and creatinine clearance.
- Peritoneal dialysis should be considered as the first line of renal replacement therapy for most ESRD patients.
- Patients on chronic peritoneal dialysis for ten years or more in North America.
- Significance, epidemiology, and prevention of peritoneal dialysis catheter infections.
- Recommended clinical practices for maximizing peritoneal dialysis clearances.
- The future of peritoneal dialysis in the United States: optimizing its use.
- Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis.
- Why is the evidence favoring hemodialysis over peritoneal dialysis misleading?
- Recommendations for clinical practice and research needs directed at reducing morbidity and mortality in peritoneal dialysis.
- Solute clearance approach to adequacy of peritoneal dialysis.
- Measurement of continuous ambulatory peritoneal dialysis prescription adherence using a novel approach.
- Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status.
- Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD).
- Effects of hemodialysis on prostate-specific antigen.
- Utilization of inpatient and outpatient resources for the management of hemodialysis access complications.
- Dialysis modality and delayed graft function after cadaveric renal transplantation.
- Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD.
- Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps.
- Role of peritoneal dialysis in the era of the resurgence of home hemodialysis.
- Should we treat patients with incremental dialysis prescriptions?
- Transitions from PD are expected. Why not continue at home?
- Incremental initiation of dialysis: one center''s experience over a two-year period.
- Adequacy of peritoneal dialysis.
- Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Managem...
- Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study.
- Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences.
- The impact of different immunosuppressant regimens on recurrent glomerulonephritis.
- Metabolic consequences of peritoneal dialysis.
- The effect of increasing hematocrit on peritoneal transport kinetics.
- A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients.
- A 69-year-old male with elevated amylase in bloody and cloudy dialysate.
- The importance of monitoring dialysis adequacy in chronic peritoneal dialysis.
- A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease.
- The dialysis outcomes quality initiative guidelines: a new standard for everybody?
- Adequacy of peritoneal dialysis--where are we going?
- Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution.
- Comparison of intraperitoneal and subcutaneous epoetin alfa in peritoneal dialysis patients.
- Monoarthritis in a patient with lupus nephritis on peritoneal dialysis.
- The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.
- An international study of patient compliance with hemodialysis.
- Prevalence of missed treatments and early sign-offs in hemodialysis patients.
- Systematic Barriers to the Effective Delivery of Home Dialysis in the United States: A Report From the Public Policy/Advocacy Committee of the North American Chapter o...
- Contemporary surgical management of renovascular disease.
- Chronic mesangiolytic glomerulopathy in a patient with SC hemoglobinopathy.
- Endocrine crises. Hypokalemia.
- Conversion from cyclosporine: status after five years.
- Renal biopsy findings in presumed hypertensive nephrosclerosis.
- Peritoneal dialysis.
- Social support and health-related quality of life in black and white dialysis patients.
- Dialysis modality distribution in the United States.
- If you can''t beat them, join them (bimodal dialysis: the best of both worlds).
- Does hypertension cause end-stage renal disease in older white patients?
- Education, research, peritoneal dialysis, and the North American chapter of the International Society for Peritoneal Dialysis.
- Usefulness of peritoneal fluid amylase levels in the differential diagnosis of peritonitis in peritoneal dialysis patients.
- A 55-year-old man with hematuria and blood-tinged dialysate.
- The Kidney Outcomes Prediction and Evaluation (KOPE) study: a prospective cohort investigation of patients undergoing hemodialysis. Study design and baseline character...
- Strategies for optimizing peritoneal dialysis catheter outcomes: catheter implantation issues.
- Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study.
- Effect of intraperitoneal fluid volume changes on esophageal pressures: studies in patients on continuous ambulatory peritoneal dialysis.
- A novel "bimodal" use of icodextrin peritoneal dialysis solutions.
- Multicenter trial of erythropoietin in patients on peritoneal dialysis.
- Clinical experience: how much earlier should patients really start renal replacement therapy?
- 6?-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study.
- Comparison of peritonitis rates using standard spike versus Y sets in CAPD.
- The costs of hospitalizations due to hemodialysis access management.
- Safe conversion from cyclosporine.
- Nutritional status assessed from anthropometric measures in the HEMO study.
- A 62-year-old man with numbness, tingling, weakness in the lower extremities and difficulty in walking.
- Racial differences in the incidence of end-stage renal disease.
- Approach to fluid management in peritoneal dialysis: a practical algorithm.
- Feasibility of a sterile splice for connection in continuous ambulatory peritoneal dialysis.
- Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
Doctors Specialties
- Audiology
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Top MD
Education
-
Rush Medical College
Drug Facts
| NPI NUMBER | 1669457891 | |
| NPPES Provider LastName | BURKART | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 271570001 | |
| NPPES Provider State | NC | |
| Specialty Description | Nephrology | |
| Total Claim Count | 621.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 31.0 | |
| Percent Opioid Claims | 4.99 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669457891 |
| Last Name Of The Provider | BURKART |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. James R. Madison, DO |
|
|
Dr. Kinya C. Kamau, MD |
|
|
Dr. Charles J. Pradieu, MD
 This Doctor is OpenDoctor Recommended.
|